Actionable insights straight to your inbox

Equities logo

Evofem Biosciences Shows Positive Top-Line Phase 3 Results for Hormone-Free Birth Control

Amphora showed 98.7% efficacy in preventing births when used correctly (Image: Evofem Biosciences)